Purchase of Mass Array

  • MHRA

F14: Notice for changes or additional information

Notice identifier: 2022/S 000-028909

Procurement identifier (OCID): ocds-h6vhtk-037529

Published 13 October 2022, 5:10pm



Section one: Contracting authority/entity

one.1) Name and addresses

MHRA

10 South Colonnade, Canary Wharf

London

E14 4PU

Email

purchasing@nibsc.org

Country

United Kingdom

Region code

UKI31 - Camden and City of London

Justification for not providing organisation identifier

Not on any register

Internet address(es)

Main address

https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency

Buyer's address

https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Purchase of Mass Array

Reference number

C103837

two.1.2) Main CPV code

  • 38000000 - Laboratory, optical and precision equipments (excl. glasses)

two.1.3) Type of contract

Supplies

two.1.4) Short description

The Agency is looking to purchase a new integrated, substantially automated platform capable of performing mid-throughput SNP genotyping, DNA Methylation analysis, Quantitative Gene Expression Analysis and Allele frequency determination on pooled samples of DNA. The system will be utilising a mass-spectrometry spectral analysis approach to complement pre-existing in-house digital PCR and NGS capabilities. The system must be capable of routinely achieving the stated number SNP genotyping per run. The order must be financially committed by NIBSC/ MHRA before 31st March 2023.Submit response via Atamis e-procurement portal (https://health-family.force.com/s/Welcome)


Section six. Complementary information

six.6) Original notice reference

Notice number: 2022/S 000-028735


Section seven. Changes

seven.1.2) Text to be corrected in the original notice

Section number

II.1.1.1

Place of text to be modified

Contract title

Instead of
Text

Purchase of Mass Array

Read
Text

Purchase of a mid-throughput DNA genotyping analysis system